Screener
Parker-Hannifin PH Capitalized research and development
Capitalized research and development at other companies
Other financials
Where this comes from
Reported directly by Parker-Hannifin in its filing.
Tagged under the XBRL concept ph:DeferredTaxAssetsCapitalizedResearchAndDevelopment.
The source filing: Parker-Hannifin’s 10-K, filed August 22, 2025.
- Filed
- Aug 22, 2025
- Fiscal year
- FY2025
- Accession
- 0000076334-25-000035
| Line item | 2025 | 2024 |
|---|---|---|
| Stock-based compensation | 38 | 34 |
| Loss carryforwards | 114 | 1,064 |
| Inventory | 70 | 68 |
| Capitalized research and development | 172 | 146 |
| Tax credit carryforwards | 45 | 36 |
| Unrealized currency exchange gains and losses | 5 | (18) |
| Undistributed foreign earnings | (32) | (30) |
| Depreciation and amortization | (1,748) | (2,104) |
ITEM 8. Financial Statements and Supplementary Data.
FAQ
- What is Parker-Hannifin's capitalized research and development?
- Parker-Hannifin (PH) reported capitalized research and development of $172M in Q2 2025.
- What is the long-term trend for Parker-Hannifin's capitalized research and development?
- Over 2 years (2023 to 2025), Parker-Hannifin's capitalized research and development has grown at a 36.6% compound annual growth rate (CAGR), from $92.19M to $172M.
- What does capitalized research and development mean?
- This represents the tax benefit associated with research and development costs that have been capitalized rather than expensed for tax purposes. It reflects the future tax savings the company expects to realize as these costs are amortized. It is a specific component of the broader deferred tax asset balance.
Ask your AI about Parker-Hannifin's capitalized research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude